Gilead: A Future Dividend Gold Mine At A Bargain Price
Gilead Sciences Inc (NASDAQ:GILD) is a drug company that might seem to be struggling, but that is due to the outsized performance of its HCV drugs, which investors should have expected to return to more normal levels. Because of expected sales declines, the current market price offers a nice opportunity to pick up what will become a solid dividend growth stock.